Drugs / TetMYB
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03287427 | Aug 2018 → Dec 2022 | adenoid cystic carcinoma, colorectal cancer | Peter MacCallum Cancer Centre, Australia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TetMYB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03287427 ↗ |
| Known as | TetMYB Vaccine | “TetMYB Vaccine is a vaccine that helps your immune system to recognise the cancer cells.” NCT03287427 ↗ |
| Modality | Vaccine | “TetMYB Vaccine is a vaccine that helps your immune system to recognise the cancer cells.” NCT03287427 ↗ |